share_log

Alzamend Neuro Files Investigational New Drug Application With FDA for Dementia Treatment ALZN002

Alzamend Neuro Files Investigational New Drug Application With FDA for Dementia Treatment ALZN002

阿爾茲修改神經文件 FDA 用於癡呆症治療 ALZN002 的研究新藥申請
MT Newswires ·  2022/09/29 11:03

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論